Evaluating Safety of Telehealth for Initial Surgical Evaluation of General Thoracic Patients

评估远程医疗在普通胸科患者初步外科评估中的安全性

阅读:3

Abstract

BACKGROUND: The use of telehealth has grown exponentially since the COVID-19 pandemic. The safety of an initial telehealth preoperative evaluation for patients undergoing general thoracic procedures is unknown. METHODS: We retrospectively reviewed all patients who underwent a general thoracic surgical procedure at our academic tertiary care institution from January 2021 to December 2022. We determined that visits were performed through telehealth or an in-person visit and linked to our institutional Society of Thoracic Surgeons database to abstract outcomes. Our outcomes of interest included complications, readmissions, intraoperative conversions, and intensive care unit admissions. Hierarchical multivariate logistic regression was used and clustered within procedure type. RESULTS: Of 1348 patients who underwent a procedure in our institution, 469 (34.8%) patients had an initial telehealth preoperative evaluation. We analyzed outcomes for 757 patients who underwent a major thoracic procedure. Patients who had an in-person visit tended to be older with worse functional status. After multivariable adjustment, an initial telehealth evaluation was associated with a lower adjusted complication rate (31.6% vs 40.4%; odds ratio, 0.63 [95% CI, 0.46-0.88]; P = .006), with no significant difference in readmissions, intensive care unit admissions, or intraoperative conversions. CONCLUSIONS: This preliminary study of the use of telehealth for preoperative evaluation of patients undergoing general thoracic procedures suggests that it is a safe and feasible alternative to an in-person evaluation. Care must be taken to ensure that this pandemic-induced trend continues to improve patient access to surgical care without worsening or creating new disparities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。